Vyome (NASDAQ:HIND) Posts Quarterly Earnings Results

Vyome (NASDAQ:HIND) released its quarterly earnings data on Friday. The company reported ($3.12) earnings per share (EPS) for the quarter, Zacks reports. Vyome had a negative net margin of 69.71% and a negative return on equity of 216.95%.

Vyome Stock Down 1.2%

Shares of HIND stock traded down $0.06 during trading hours on Friday, hitting $4.87. 28,524 shares of the company were exchanged, compared to its average volume of 396,517. The company has a market cap of $17.82 million, a price-to-earnings ratio of -0.01 and a beta of 1.15. Vyome has a fifty-two week low of $4.71 and a fifty-two week high of $594.00.

Wall Street Analyst Weigh In

HIND has been the subject of several recent research reports. Maxim Group restated a “buy” rating and issued a $15.00 price target on shares of Vyome in a research report on Thursday, October 2nd. Citigroup upgraded Vyome to a “buy” rating in a report on Thursday, October 2nd. Finally, Wall Street Zen raised Vyome from a “sell” rating to a “hold” rating in a research report on Thursday, October 9th. Two equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $15.00.

About Vyome

ReShape Lifesciences Inc, a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract.